Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-01-02 Sale |
2025-01-03 7:31 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
9,437 | $3.1517 | $29,743 | 108,951 (Direct) |
View |
| 2024-07-17 Sale |
2024-07-18 7:06 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
2,598 | $3.7011 | $9,615 | 118,388 (Direct) |
View |
| 2024-07-02 Sale |
2024-07-02 9:19 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
6,051 | $3.2685 | $19,778 | 120,986 (Direct) |
View |
| 2024-01-03 Sale |
2024-01-05 7:00 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
12,956 | $4.4859 | $58,119 | 99,970 (Direct) |
View |
| 2023-07-03 Sale |
2023-07-06 7:08 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
12,103 | $3.3112 | $40,075 | 112,926 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 5:36 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
6,568 | $4.1779 | $27,440 | 58,057 (Direct) |
View |
| 2022-07-05 Sale |
2022-07-07 8:17 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
5,835 | $2.6315 | $15,355 | 64,625 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-05 8:32 pm |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
4,727 | $3.1989 | $15,121 | 31,342 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-07 Option Award |
2025-02-11 6:55 pm |
N/A 2035-02-06 |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
114,062 | $0 | 223,013 (Direct) |
View |
| 2024-02-12 Option Award |
2024-02-14 6:00 pm |
N/A 2034-02-11 |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
64,533 | $0 | 164,503 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 4:50 pm |
N/A 2033-02-09 |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
160,000 | $0 | 218,057 (Direct) |
View |
| 2022-03-03 Option Award |
2022-03-15 1:37 pm |
N/A 2032-03-02 |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
95,000 | $0 | 126,342 (Direct) |
View |
| 2021-02-17 Option Award(A) |
2021-02-23 4:24 pm |
N/A N/A |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
36,069 | $0 | 36,069 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 7:25 pm |
N/A 2031-02-26 |
PUMA BIOTECHNOLOGY INC. | PBYI | Ludwig Jeffrey Jerome Chief Commercial Officer |
86,809 | $0 | 86,809 (Direct) |
View |